620
Participants
Start Date
October 31, 2013
Primary Completion Date
April 30, 2014
Study Completion Date
April 30, 2014
FF
Dry white powder containing 100mcg of Fluticasone Furoate blended with lactose per blister was administered by DPI.
VI
Dry white powder containing 25mcg of Vilanterol micronised drug (as the 'M' salt triphenylacetate) blended with lactose and magnesium stearate per blister was administered by DPI.
UMEC
Umeclidinium bromide in a powder blend with lactose and magnesium stearate was used at two different doses 62.5mcg and 125mcg.
Placebo
The matching placebo DPI identical in appearance to the inhaler containing active study medication.
GSK Investigational Site, Berlin
GSK Investigational Site, Berlin
GSK Investigational Site, Berlin
GSK Investigational Site, Schwerin
GSK Investigational Site, Hamburg
GSK Investigational Site, Hamburg
GSK Investigational Site, Newport News
GSK Investigational Site, Reinfeld
GSK Investigational Site, Charlotte
GSK Investigational Site, Spartanburg
GSK Investigational Site, Gaffney
GSK Investigational Site, Greenville
GSK Investigational Site, Rock Hill
GSK Investigational Site, Hanover
GSK Investigational Site, Hanover
GSK Investigational Site, DeLand
GSK Investigational Site, Orlando
GSK Investigational Site, Kassel
GSK Investigational Site, Mobile
GSK Investigational Site, Tábor
GSK Investigational Site, Magdeburg
GSK Investigational Site, Essen
GSK Investigational Site, Essen
GSK Investigational Site, Osnabrück
GSK Investigational Site, Cologne
GSK Investigational Site, Düren
GSK Investigational Site, Koblenz
GSK Investigational Site, Witten
GSK Investigational Site, Frankfurt am Main
GSK Investigational Site, Neu-Isenburg
GSK Investigational Site, Saint Charles
GSK Investigational Site, Stuttgart
GSK Investigational Site, Sunset
GSK Investigational Site, Ostrava - Poruba
GSK Investigational Site, Munich
GSK Investigational Site, Coeur d'Alene
GSK Investigational Site, Phoenix
GSK Investigational Site, Dillingen an der Donau
GSK Investigational Site, Huntington Beach
GSK Investigational Site, Kralupy nad Vltavou
GSK Investigational Site, Olomouc
GSK Investigational Site, Prague
GSK Investigational Site, Teplice
GSK Investigational Site, Dresden
GSK Investigational Site, Leipzg
GSK Investigational Site, Leipzig
GSK Investigational Site, Leipzig
GSK Investigational Site, Leipzig
GSK Investigational Site, Gera
GSK Investigational Site, Schmölln
GSK Investigational Site, Daegu
GSK Investigational Site, Gangwon-do
GSK Investigational Site, Seoul
GSK Investigational Site, Seoul
GSK Investigational Site, Seoul
GSK Investigational Site, Seoul
GSK Investigational Site, Seoul
Lead Sponsor
GlaxoSmithKline
INDUSTRY